Dvojica

27/02/2026

Bohlen and colleagues report that the E3 ubiquitin ligase CBL is necessary for the development, tolerance and activation of B cells in humans, unlike in mice where CBL deficiency results in loss of T cells.

13/02/2026

13/02/2026

Phenotypic discovery and therapeutic evaluation of an ITGA3B1-targeting antibody-drug conjugate for bladder cancer. https://hubs.li/Q03_w6Fc0

13/02/2026

The plastidial phosphorylase Pho1 co-localizes in situ with Photosystem I-associated PsaC as assessed by double labeling immunocytochemistry – transmission electron microscopy. Learn more with the following article https://hubs.li/Q03_wlSw0

13/02/2026

This study aimed to investigate the inflammatory mechanisms induced by the toxic aldehyde acrolein in proliferative diabetic retinopathy (PDR). Nε‐(3‐formyl‐3, 4‐dehydropiperidino) lysine adduct (FDP‐lys), an acrolein‐binding protein, and chemokine ...

13/02/2026

The ability to predict the values of immunohistochemical (IHC) biomarkers noninvasively for brain tumors is an important diagnostic task, accelerating the medical decision-making process and reducing the burden on the patient. In this work, the ...

22/01/2026

Specializing in Secondary Antibodies and Conjugates - For Western Blotting, IHC, ICC, Flow Cytometry, ELISA and other immunological applications.

22/01/2026

Angiopoietin-2 aggravates Alzheimer’s disease by promoting blood-brain barrier dysfunction and neuroinflammation. Learn more at https://hubs.li/Q03--4sw0

22/01/2026

Schizophrenia is a heterogeneous psychiatric disorder that remains inadequately treated with current therapies. Developing appropriate animal models that reflect the broad spectrum of schizophrenia symptoms is crucial for advancing our understanding of the disease and identifying effective treatment...

22/01/2026

Impaired Generation of High-Affinity Memory B Cells and Neutralizing Antibodies Against SARS-CoV-2 in Adolescents and Young Adults With Juvenile Idiopathic Arthritis Treated With Tumor Necrosis Factor Inhibitors. https://hubs.li/Q03--kJd0

22/01/2026

Fibroblast growth factor 1 (FGF1), a well-characterized member of the FGF family, effectively lowers blood glucose levels in animal models of type 2 diabetes by stimulating glucose uptake. However, its significant mitogenic potential poses a major challenge for clinical application. Here, we present...